World's Best Scientists 2026 revealed!
Award Badge
Immunology
Netherlands
2022

D-Index & Metrics

Immunology

D-Index
111
Citations
43704
World Ranking
475
National Ranking
18

Paul W. H. I. Parren publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Paul W. H. I. Parren sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 371 publications — 77th percentile

77% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Paul W. H. I. Parren D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Paul W. H. I. Parren sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 111 D-Index — 91st percentile

91% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 2022 - Research.com Immunology in Netherlands Leader Award

Overview

Paul W. H. I. Parren is affiliated with Leiden University Medical Center in the Netherlands. Their research spans multiple fields and topics primarily within medicine and immunology, with a substantial focus on antibody-related studies and cancer immunotherapy.

The main fields of study associated with this scientist include:

  • Medicine
  • Immunology and Microbiology

Within these fields, more specific subfields reflect their research interests:

  • Immunology
  • Radiology, Nuclear Medicine and Imaging
  • Oncology
  • Genetics
  • Molecular Biology

Key research topics covered by their work encompass:

  • Monoclonal and Polyclonal Antibodies Research
  • CAR-T cell therapy research
  • Immune Cell Function and Interaction
  • Complement system in diseases
  • T-cell and B-cell Immunology
  • Chronic Lymphocytic Leukemia Research
  • Systemic Lupus Erythematosus Research

Their recent publication record includes studies that address mechanisms of antibody function, cancer immunotherapy, and novel antibody therapeutics. Notable recent papers are:

  • Avidity in antibody effector functions and biotherapeutic drug design (2022) published in Nature Reviews Drug Discovery
  • Gamma Delta T-Cell Based Cancer Immunotherapy: Past-Present-Future (2022) published in Frontiers in Immunology
  • DuoBody-CD3xCD20 induces potent T-cell-mediated killing of malignant B cells in preclinical models and provides opportunities for subcutaneous dosing (2020) published in EBioMedicine
  • Discovery of amivantamab (JNJ-61186372), a bispecific antibody targeting EGFR and MET (2021) published in Journal of Biological Chemistry
  • DuoHexaBody-CD37®, a novel biparatopic CD37 antibody with enhanced Fc-mediated hexamerization as a potential therapy for B-cell malignancies (2020) published in Blood Cancer Journal

Their work appears frequently in several scientific venues, reflecting consistent contributions to immunology and cancer research literature. These venues include:

  • Frontiers in Immunology
  • Proceedings of the National Academy of Sciences
  • Cancer Immunology Research
  • Journal of Clinical Oncology
  • bioRxiv (Cold Spring Harbor Laboratory)

Throughout their career, Paul W. H. I. Parren has collaborated often with fellow researchers. Frequent co-authors with multiple joint publications include:

  • Janine Schuurman
  • Hans van Vliet
  • Tanja D. de Gruijl
  • Arnon P. Kater
  • Leendert A. Trouw

Best Publications

  • Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody

    Dennis R. Burton;Jayashree Pyati;Raju Koduri;Stephen J. Sharp

  • Bispecific antibodies: a mechanistic review of the pipeline.

    Aran F Labrijn;Maarten L Janmaat;Janice M Reichert;Paul W H I Parren

  • Daratumumab, a novel therapeutic human CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological tumors

    Michel De Weers;Yu Tzu Tai;Michael S. Van Der Veer;Joost M. Bakker

  • HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites

    Peter D. Kwong;Peter D. Kwong;Michael L. Doyle;Michael L. Doyle;David J. Casper;Claudia Cicala

  • Crystal structure of a neutralizing human IGG against HIV-1: a template for vaccine design.

    Erica Ollmann Saphire;Paul W. H. I. Parren;Ralph Pantophlet;Michael B. Zwick

  • Anti-Inflammatory Activity of Human IgG4 Antibodies by Dynamic Fab Arm Exchange

    Marijn van der Neut Kolfschoten;Janine Schuurman;Mario Losen;Wim K. Bleeker

  • Fc receptor but not complement binding is important in antibody protection against HIV

    Ann J. Hessell;Lars Hangartner;Meredith Hunter;Carin E. G. Havenith

  • Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41.

    Michael B. Zwick;Aran F. Labrijn;Meng Wang;Catherine Spenlehauer

  • Complement is activated by IgG hexamers assembled at the cell surface.

    Christoph A. Diebolder;Christoph A. Diebolder;Frank J. Beurskens;Rob N. de Jong;Roman I. Koning

  • Characterization of new human CD20 monoclonal antibodies with potent cytolytic activity against non-Hodgkin lymphomas

    Jessica L Teeling;Ruth R French;Mark S Cragg;Jeroen van den Brakel

  • Antibody Protects Macaques against Vaginal Challenge with a Pathogenic R5 Simian/Human Immunodeficiency Virus at Serum Levels Giving Complete Neutralization In Vitro

    Paul W. H. I. Parren;Preston A. Marx;Preston A. Marx;Ann J. Hessell;Amara Luckay

  • The Biological Activity of Human CD20 Monoclonal Antibodies Is Linked to Unique Epitopes on CD20

    Jessica L. Teeling;Wendy J.M. Mackus;Luus J.J.M. Wiegman;Jeroen H.N. van den Brakel

  • Human monoclonal antibodies against cd20

    Jessica Woodmill Cottage Teeling;Sigrid Ruuls;Martin Glennie;Jan G. J. Van De Winkel

  • Effective, low-titer antibody protection against low-dose repeated mucosal SHIV challenge in macaques.

    Ann J Hessell;Pascal Poignard;Meredith Hunter;Lars Hangartner

  • Antibody-mediated phagocytosis contributes to the anti-tumor activity of the therapeutic antibody daratumumab in lymphoma and multiple myeloma

    M. B. Overdijk;S. Verploegen;M. Bogels;M. van Egmond

  • Effector Function Activities of a Panel of Mutants of a Broadly Neutralizing Antibody against Human Immunodeficiency Virus Type 1

    Marjan Hezareh;Ann J. Hessell;Richard C. Jensen;Jan G. J. van de Winkel

  • On the interaction of IgG subclasses with the low affinity Fc gamma RIIa (CD32) on human monocytes, neutrophils, and platelets. Analysis of a functional polymorphism to human IgG2.

    P. W. H. I. Parren;P. A. M. Warmerdam;L. C. M. Boeije;J. Arts

  • Therapeutic IgG4 antibodies engage in Fab-arm exchange with endogenous human IgG4 in vivo

    Aran F Labrijn;Antonio Ortiz Buijsse;Ewald T J van den Bremer;Annemiek Y W Verwilligen

  • The neutralizing antibody response to HIV-1: viral evasion and escape from humoral immunity.

    P. W. H. I Parren;J. P Moore;D. R Burton;Q. J Sattentau

  • Efficient generation of stable bispecific IgG1 by controlled Fab-arm exchange

    Aran F. Labrijn;Joyce I. Meesters;Bart E. C. G. de Goeij;Ewald T. J. van den Bremer

  • Statins impair antitumor effects of rituximab by inducing conformational changes of CD20.

    Magdalena Winiarska;Jacek Bil;Ewa Wilczek;Grzegorz M Wilczynski

Frequent Co-Authors

Jan G. J. van de Winkel
Jan G. J. van de Winkel Genmab (United States)
Dennis R. Burton
Dennis R. Burton Scripps Research Institute
Ronald P. Taylor
Ronald P. Taylor University of Virginia
Tuna Mutis
Tuna Mutis Vrije Universiteit Amsterdam
Thomas Valerius
Thomas Valerius Kiel University
Margaret A. Lindorfer
Margaret A. Lindorfer University of Virginia
Matthias Peipp
Matthias Peipp Kiel University
Ole Baadsgaard
Ole Baadsgaard Genmab (United States)
Erica Ollmann Saphire
Erica Ollmann Saphire La Jolla Institute For Allergy & Immunology
Henrik J. Ditzel
Henrik J. Ditzel University of Southern Denmark

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology, pursuing related healthcare degrees can open diverse career opportunities. Many professionals explore advanced nursing roles, such as psychiatric mental health nurse practitioners, where one can find cheapest pmhnp certificate programs available online to start or advance their careers efficiently.

Nurse practitioners specializing in acute or specialized care can further boost their earning potential. Understanding the variations in dnp salary by region helps in making informed decisions about where to study and work. For those transitioning careers, programs focusing on acute care nurse practitioner programs offer tailored pathways to expand clinical expertise.

Additionally, accelerated paths make it feasible to quickly move into nurse practitioner roles, combining rigorous academics with practical experience. Exploring the range of accelerated nurse practitioner programs online can help candidates find programs that fit their schedules and career goals.

Best Scientists Citing Paul W. H. I. Parren

Trending Scientists

Recently Published Articles